Page last updated: 2024-10-18

dihydroxyphenylalanine and Lymphoma

dihydroxyphenylalanine has been researched along with Lymphoma in 2 studies

Dihydroxyphenylalanine: A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific.
dopa : A hydroxyphenylalanine carrying hydroxy substituents at positions 3 and 4 of the benzene ring.

Lymphoma: A general term for various neoplastic diseases of the lymphoid tissue.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Helson, L1
Johnson, GA1
Smith, R1
Inoi, T1
Mojamdar, M1
Ichihashi, M1
Mishima, Y1

Other Studies

2 other studies available for dihydroxyphenylalanine and Lymphoma

ArticleYear
DOPA metabolism in neuroblastoma.
    Medical and pediatric oncology, 1980, Volume: 8, Issue:4

    Topics: Adolescent; Bone Neoplasms; Brain Neoplasms; Child; Dihydroxyphenylalanine; False Negative Reactions

1980
[Correlation of urinary 5-S-cysteinyldopa with repeated remission of melanoma induced by DTIC combination chemotherapy].
    Nihon Hifuka Gakkai zasshi. The Japanese journal of dermatology, 1982, Volume: 92, Issue:10

    Topics: Cysteinyldopa; Dacarbazine; Dihydroxyphenylalanine; Female; Humans; Lymphoma; Melanoma; Middle Aged;

1982